Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technosphere Insulin Safety Follow-Up in Type 2 Diabetes
NCT00754624Phase 2Completed
- Sponsor
- MannKind
- Start
- May 2004
- Primary completion
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of TI-Inhalation Powder B in type 2 diabetes mellitus (T2DM), sponsored by MannKind. Started May 2004; status: completed.
02
Drugs
TI-Inhalation Powder B
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00754624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754624.